Kinase Drug Discovery / ISSN (ePub)

Name: Kinase Drug Discovery / ISSN
Brand: RSC
SKU: 108825811
Price: 252.99 EUR
Availability: OnlineOnly

Modern Approaches (Sprache: Englisch)

Schreiben Sie einen Kommentar zu "Kinase Drug Discovery / ISSN".

Merken

Mehr zum Inhalt Autorenporträt Video

sofort als Download lieferbar

Bestellnummer: 108825811

eBook (ePub) 252.99 €

Download bestellen

Verschenken

126 DeutschlandCard Punkte sammeln

Lastschrift, Kreditkarte, Paypal, Rechnung
Kostenloser tolino webreader

Produktdetails

Produktbeschreibung
Autorenporträt
eBook Hilfe
Biblio. Angaben / Produktdetails
Download-DRM Infos

Produktinformationen zu „Kinase Drug Discovery / ISSN (ePub)“

Kinase inhibition remains an area of significant interest, and growing importance, across academia and the pharmaceutical industry. There are now many marketed drugs that target kinases and a significant number of compounds are currently in various stages of clinical development. This book is a forward-looking analysis of a number of key areas for kinase inhibition in the coming years and builds on the first volume. This includes topics such as screening approaches to target kinases along with different modes of inhibition such as allosteric and covalent. Novel approaches such as macrocyclisation are considered along with how the properties of kinase inhibitors have evolved, including the potential for brain penetration. Recent areas of great importance also covered include cutting edge molecular modelling approaches and the importance of kinase mutations. The evolving biology of kinases has also resulted in increased interest in the immuno-oncology area and also pseudokinases as a target family. As with the first volume the book finishes with a forward looking view of how research against this fascinating target class may evolve.

Autoren-Porträt

Dr Frederick W Goldberg is a Medicinal Chemist at AstraZeneca, UK. He received his MSci at Cambridge University, PhD at Imperial College London and a Postdoc (Fulbright scholarship) at the University of Texas at Austin. He has extensive experience of leading both chemistry and project teams within oncology, including targets that have delivered clinical candidates. He has over 30 published papers and patents, including a number of research papers and perspective articles on kinases. Dr Richard A Ward is a Computational Medicinal Chemist at AstraZeneca, UK. He received his BSc (Hons) in Chemistry with Bio-organic Chemistry at The University of Birmingham and gained a PhD in Computational Chemistry also at The University of Birmingham, under the supervision of Dr John Wilkie. He has extensive experience in target selection, lead generation and lead optimisation against kinase and non-kinase targets with a specialisation in covalent drug discovery. Along with publishing a number of papers on kinases, Richard is a co-inventor of the EGFR mutant kinase inhibitor osimertinib.

eBook Hilfe

Informationen und Hilfe zu eBooks hier klicken!

Bibliographische Angaben

2018, 1. Auflage, 413 Seiten, Englisch
Herausgegeben: Richard A Ward, Frederick W Goldberg
Verlag: RSC
ISBN-10: 1788015630
ISBN-13: 9781788015639
Erscheinungsdatum: 31.10.2018

Abhängig von Bildschirmgröße und eingestellter Schriftgröße kann die Seitenzahl auf Ihrem Lesegerät variieren.

eBook Informationen

Dateiformat: ePub3.0
Größe: 11 MB
Mit Kopierschutz

Sprache:

Englisch

Kopierschutz

Dieses eBook können Sie uneingeschränkt auf allen Geräten der tolino Familie lesen. Zum Lesen auf sonstigen eReadern und am PC benötigen Sie eine Adobe ID.

Kommentar zu "Kinase Drug Discovery / ISSN"

Schreiben Sie einen Kommentar zu "Kinase Drug Discovery / ISSN".

Wie funktionieren Bewertungen?

0 Gebrauchte Artikel zu „Kinase Drug Discovery / ISSN“

Zustand	Preis	Porto	Zahlung	Verkäufer	Rating